Biotin Anti-Human CD29 Antibody[TS2/16.2.1]

Introducing the BIOTIN ANTI-HUMAN CD29 ANTIBODY[TS2/16.2.1], a highly specialized and meticulously crafted product designed to cater to the discerning needs of scientific research and diagnostic applications. This antibody, with its exceptional specificity and affinity towards the human CD29 antigen, offers an invaluable tool for the investigation and understanding of cellular adhesion processes.

The BIOTIN ANTI-HUMAN CD29 ANTIBODY[TS2/16.2.1] is meticulously developed using cutting-edge technology and rigorous quality control measures, ensuring its reliability and reproducibility. Its biotin conjugation further enhances its versatility, enabling seamless integration into various experimental setups and facilitating downstream applications.

This antibody's exceptional binding affinity towards the CD29 antigen, a crucial cell surface glycoprotein involved in cell adhesion and migration, empowers researchers to delve deeper into the intricate mechanisms governing cellular interactions. By targeting CD29, this antibody enables the elucidation of vital cellular processes, including embryogenesis, tissue development, immune response modulation, and cancer metastasis.

The BIOTIN ANTI-HUMAN CD29 ANTIBODY[TS2/16.2.1] exhibits exceptional specificity, ensuring minimal cross-reactivity with non-targeted antigens. This attribute, coupled with its high sensitivity, guarantees accurate and reliable results, thereby enhancing the credibility of scientific investigations and diagnostic procedures.

Furthermore, this antibody's biotin conjugation offers unparalleled convenience and flexibility. Its compatibility with various detection systems, such as avidin-biotin complex (ABC) methods, streptavidin-based assays, and fluorescence-based techniques, allows for seamless integration into diverse experimental protocols. This adaptability empowers researchers to explore a wide range of applications, including flow cytometry, immunohistochemistry, immunofluorescence, and Western blotting.

In summary, the BIOTIN ANTI-HUMAN CD29 ANTIBODY[TS2/16.2.1] stands as a pinnacle of scientific excellence, meticulously engineered to meet the exacting demands of modern research and diagnostic endeavors. Its exceptional specificity, affinity, and biotin conjugation render it an indispensable tool for unraveling the complexities of cellular adhesion processes, thereby advancing our understanding of fundamental biological phenomena.